Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Toxicological Sciences

• Publication date

  2005-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/TOXSCI/KFI305PMID 16141437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis

  2005cited by this paper
• The potential of statins as part of anti-cancer treatment.

  2005cited by this paper
• Delineation of Myotoxicity Induced by 3-Hydroxy-3-methylglutaryl CoA Reductase Inhibitors in Human Skeletal Muscle Cells

  2005cited by this paper
• Delineation of myotoxicity induced by HMG-CoA-reductase-inhibitors in human skeletal muscle cells

  2005cited by this paper
• Lovastatin-induced apoptosis in human melanoma cell lines

  2005cited by this paper
• Pleiotropic effects of statins.

  2005cited by this paper
• Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle.

  2005cited by this paper
• Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity

  2005influential reference
• Potential Interactions between Exercise and Drug Therapy

  2004influential reference
• Statins and Diabetes

  2004cited by this paper
• Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.

  2004cited by this paper
• McArdle's disease diagnosed following statin-induced myositis

  2004cited by this paper
• Statin precipitated lactic acidosis?

  2004cited by this paper
• Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats.

  2004influential reference
• Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone.

  2004influential reference
• Mitochondrial alterations in muscle biopsies of patients on statin therapy.

  2004cited by this paper
• Exercise alters the profile of phospholipid molecular species in rat skeletal muscle.

  2004influential reference
• Physical exercise and binding of digoxin to skeletal muscle — Effect of muscle activation frequency

  2004cited by this paper
• Human skeletal muscle fiber type alteration with high-intensity intermittent training

  2004cited by this paper
• Ultrastructure of mouse striated muscle fibers following pravastatin administration

  2004cited by this paper
• Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis.

  2004cited by this paper
• Issues in statin-associated myopathy.

  2003cited by this paper
• Statin-associated myopathy with normal creatine kinase levels.

  2003cited by this paper
• A Comprehensive Description of Muscle Symptoms Associated with Lipid-Lowering Drugs

  2003influential reference
• Differential transcriptional activation of select metabolic genes in response to variations in exercise intensity and duration.

  2003cited by this paper
• Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio.

  2003cited by this paper
• Issues in statin-associated myopathy.

  2003cited by this paper
• Statin-associated myopathy.

  2003cited by this paper
• Effects of simvastatin administration in an experimental model of cancer cachexia.

  2003cited by this paper
• All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells.

  2003cited by this paper
• Cerivastatin and reports of fatal rhabdomyolysis.

  2002cited by this paper
• Safety considerations for statins

  2002cited by this paper
• Statin-Associated Myopathy with Normal Creatine Kinase Levels

  2002cited by this paper
• Statin‐associated myopathy

  2001cited by this paper
• Statin myopathies: pathophysiologic and clinical perspectives.

  2001cited by this paper
• Pleiotropic effects of statins

  2000cited by this paper
• Plasma concentrations of active simvastatin acid are increased by gemfibrozil

  2000cited by this paper
• HMG-CoA Reductase Inhibitors and Myotoxicity

  2000cited by this paper
• New insights into the pharmacodynamic and pharmacokinetic properties of statins.

  1999cited by this paper
• Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.

  1999cited by this paper
• Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.

  1998cited by this paper
• Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor.

  1998cited by this paper
• Lovastatin increases exercise-induced skeletal muscle injury.

  1997cited by this paper
• Experimental Lovastatin Myopathy

  1993cited by this paper
• Lovastatin use and muscle damage in healthy volunteers undergoing eccentric muscle exercise.

  1991cited by this paper
• Studies on the Mechanism of Simvastatin-Induced Thyroid Hypertrophy and Follicular Cell Adenoma in the Rat

  1991cited by this paper
• Effects of exercise and lovastatin on serum creatine kinase activity.

  1991cited by this paper
• Discovery, biochemistry and biology of lovastatin.

  1988cited by this paper

• Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity

  2023cites this paper
• Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond

  2022cites this paper
• A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management

  2021cites this paper
• The Role of the Mitochondria in SAMS

  2020cites this paper
• Mechanisms of statin-associated skeletal muscle-associated symptoms.

  2020cites this paper
• Coenzyme Q10 and SAMS

  2020cites this paper
• A novel investigation of statins myotoxic mechanism: effect of atorvastatin on respiratory muscles in hypoxic environment.

  2019cites this paper
• Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle.

  2019cites this paper
• Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses

  2019cites this paper
• Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance.

  2019cites this paper
• A Mechanism for Statin-Induced Susceptibility to Myopathy

  2019cites this paper
• Regulation of lactate production through p53/β-enolase axis contributes to statin-associated muscle symptoms

  2019cites this paper
• Statin use in carnitine palmitoyltransferase II deficiency.

  2019cites this paper
• Drug-Induced Mitochondrial Toxicity

  2018cites this paper
• PGC-1β modulates statin-associated myotoxicity in mice

  2018cites this paper
• Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations

  2018cites this paper
• The Evolution of Mitochondrial Toxicity Assessment in Industry

  2018cites this paper
• Validation of a clinically‐relevant rodent model of statin‐associated muscle symptoms for use in pharmacological studies

  2018cites this paper
• Plasma 2-hydroxyglutarate, a promising prognostic biomarker candidate for skeletal muscle injury in Fischer 344 rats.

  2018cites this paper
• Endurance exercise increases the protein levels of PGC-1α and respiratory chain complexes in mouse skeletal muscle during atorvastatin administration

  2018cites this paper
• Plasma 2-hydroxyglutarate and hexanoylcarnitine levels are potential biomarkers for skeletal muscle toxicity in male Fischer 344 rats.

  2017cites this paper
• Effect of moxibustion at Shénquè ( CV 8) on anti-exercise-induced fatigue in exhaustive rats in varying degrees

  2017cites this paper
• Mitochondrial Oxidative Stress and Calcium-Dependent Permeability Transition are Key Players in the Mechanisms of Statins-Associated Side Effects

  2017cites this paper
• PGC-1β prevents statin-associated myotoxicity in oxidative skeletal muscle

  2017cites this paper
• Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis

  2017cites this paper
• Experimental study on the effect of moxibustion at Shenque (CV 8) for long-term exercise-induced fatigue

  2017cites this paper
• Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model.

  2016cites this paper
• Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle

  2016influential citation
• The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy

  2016cites this paper
• A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles

  2016cites this paper
• Treatment of Dyslipidemia with Statins and Physical Exercises: Recent Findings of Skeletal Muscle Responses

  2015cites this paper
• Treatment of Dyslipidemia with Statins and Physical Exercises: Recent Findings of Skeletal Muscle Responses.

  2015cites this paper
• Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem Cells

  2015cites this paper
• The impact of physical activity on statin-associated skeletal muscle myopathy

  2015cites this paper
• Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise

  2014cites this paper
• Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies.

  2014cites this paper
• Statins and musculoskeletal conditions, arthropathies, and injuries.

  2013cites this paper
• Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice

  2013cites this paper
• Hydrophobic statins induce autophagy and cell death in human rhabdomyosarcoma cells by depleting geranylgeranyl diphosphate.

  2012cites this paper
• Effect of statins on creatine kinase levels before and after a marathon run.

  2012cites this paper
• Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.

  2012cites this paper
• Integration of Transcriptomic and Metabolomic Profiling to Identify Mechanisms and Biomarkers of Statin-Induced Myopathy

  2012influential citation
• Er cysteinproteasene legumain og cathepsin B involvert i statinindusert myotoksisitet

  2012influential citation
• Muscle damage and inflammation following a three-day trail run

  2012influential citation
• Effect of Statins on Skeletal Muscle: Exercise, Myopathy, and Muscle Outcomes

  2012cites this paper
• Muscle damage and inflammation following a three-day trail run

  2012cites this paper
• EFFECT OF PHYSICAL EXERCISE AND STATINS ON THE MUSCLE FUNCTION IN ANIMALS WITH DYSLIPIDEMIA

  2012cites this paper
• Efeito do exercício físico e estatinas na função muscular em animais com dislipidemia

  2012cites this paper
• Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers.

  2012cites this paper
• Mitochondrial membrane potential measurement of H9c2 cells grown in high-glucose and galactose-containing media does not provide additional predictivity towards mitochondrial assessment.

  2011cites this paper
• Statin‐associated changes in skeletal muscle function and stress response after novel or accustomed exercise

  2011influential citation
• Mitochondria as a Biosensor for Drug-induced Toxicity – Is It Really Relevant?

  2011cites this paper
• ASSOCIAÇÃO ENTRE MIOPATIA INDUZIDA POR ESTATINAS E EXERCÍCIO FÍSICO

  2011cites this paper
• Statin-associated skeletal muscle damage and its interactions with novel or accustomed exercise

  2011cites this paper
• Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats.

  2011cites this paper
• Potential metabolic consequences of statins in sepsis*

  2011cites this paper
• Statin‐associated myopathy and its exacerbation with exercise

  2010influential citation
• Potential biomarkers of muscle injury after eccentric exercise

  2010cites this paper
• Estudo das respostas bioquímica e muscular da administração de estatina e sua descontinuidade associadas à atividade física em ratos

  2010cites this paper
• Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin.

  2009cites this paper
• Investigation of gene expression in C(2)C(12) myotubes following simvastatin application and mechanical strain.

  2009cites this paper
• Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy

  2009cites this paper
• The Journal of Toxicological Sciences

  2009cites this paper
• Muscle Response to the Association of Statin and Physical Exercise in Rats Respuestas Musculares de la Asociación de Estatina y Ejercicio Físico Aeróbico en Ratas

  2009cites this paper
• New insights into mechanisms of statin-associated myotoxicity.

  2008cites this paper
• Atorvastatinin Sıçan İskelet Kasında Oluşturduğu Yapısal Değişikliklerin Elektron Mikroskobu ile Değerlendirilmesi

  2008cites this paper
• Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.

  2008cites this paper
• Statin Adverse Effects

  2008cites this paper
• Rosuvastatin: Characterization of Induced Myopathy in the Rat

  2008influential citation
• Effect of cerivastatin on peripheral capillary permeability to albumin and peripheral nerve function in diabetic rats.

  2007cites this paper
• Idiosyncratic toxicity: a convergence of risk factors.

  2007cites this paper
• Bibliography. Current world literature. Vasculitis syndromes.

  2007cites this paper
• The significance of mitochondrial toxicity testing in drug development.

  2007cites this paper
• Myotoxicity associated with lipid-lowering drugs

  2007cites this paper
• Rab‐small GTPases are involved in fluvastatin and pravastatin‐induced vacuolation in rat skeletal myofibers

  2007cites this paper
• The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

  2007cites this paper
• Statin-induced apoptosis and skeletal myopathy.

  2006cites this paper